Arcadia Biosciences Reports Q3 Revenue Growth of 24.6% and GAAP EPS of $0.29
Arcadia Biosciences (RKDA) has released its third-quarter financial results, reporting a GAAP earnings per share (EPS) of $0.29. The company saw significant top-line growth, with total revenue reaching $1.62 million, representing a 24.6% increase compared to the same period last year. The results indicate steady year-over-year momentum in revenue generation for the biotechnology firm. While specific drivers for the revenue increase were not detailed in the brief announcement, the double-digit growth suggests expanding market activity or product adoption.
Tickers: $RKDA
Topics: earnings GAAP EPS revenue growth